Abstract Details

Title Aldehyde Adducts Block DOPAL Toxicity: A New Therapeutic Strategy for Parkinson Disease

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 097

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
William J. Burke, MD, PhD, FAAN	No disclosure on file
W. Michael Panneton, PhD	No disclosure on file
Naomi Lubarr, MD (Mount Sinai Beth Israel Medical Center)	Dr. Lubarr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for applied therapeutics.
Vijay B. Kumar (VA Medical Center/St. Louis University)	No disclosure on file
Adrian Holden, MD (Allergan)	No disclosure on file

��ɫ����